Ricerca
Didattica
Soluzioni
Accedi
IT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Ophthalmology,
Division of Research,
Department of Ophthalmology, Division of Research
Nathaniel Parsons has not added Biography.
If you are Nathaniel Parsons and would like to personalize this page please email our Author Liaison for assistance.
Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization.
Molecular therapy. Methods & clinical development Jun, 2018 | Pubmed ID: 29234687
Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study.
Translational vision science & technology Jan, 2018 | Pubmed ID: 29359109
Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model.
Translational vision science & technology Mar, 2018 | Pubmed ID: 29576927
Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.
Molecular immunology 04, 2019 | Pubmed ID: 30763805
Medical University of South Carolina
Marwa Belhaj1,
Balasubramaniam Annamalai2,
Nathaniel Parsons2,
Andrew Shuler1,
Jay Potts1,
Bärbel Rohrer2,3,4
1Department of Cell Biology, University of South Carolina,
2Department of Ophthalmology, Division of Research, Medical University of South Carolina,
3Department of Neuroscience, Division of Research, Medical University of South Carolina,
4Division of Research, Ralph H. Johnson VA Medical Center
Riservatezza
Condizioni di utilizzo
Politiche
Contattaci
SUGGERISCI JOVE ALLA BIBLIOTECA
Newsletter di JoVE
JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Autori
Personale delle biblioteche
Accesso
CHI SIAMO
Copyright © 2024 MyJoVE Corporation. Tutti i diritti riservati